1
|
Wu J, Zhang W, Xu J, Wang Y, He X. Anti-Neuroinflammatory Labdane Diterpenoids From the Rhizomes of Alpinia zerumbet. Chem Biodivers 2025:e202500154. [PMID: 40062790 DOI: 10.1002/cbdv.202500154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2025] [Revised: 03/10/2025] [Accepted: 03/10/2025] [Indexed: 03/25/2025]
Abstract
Alpinia zerumbet, commonly known as shell ginger, is a plant of significant ornamental and medicinal value. In the present study, nine labdane-type diterpenoids, including four novel (1-4) and five known (5-9), were isolated and identified from the rhizomes of A. zerumbet. Anti-neuroinflammatory activities of the isolated labdane-type diterpenoids were evaluated in lipopolysaccharide (LPS)-stimulated microglia BV2 cells. Compounds 3, 5, 6, and 8 could significantly inhibit the production of nitric oxide (NO) in LPS-stimulated BV2 cells. Among them, the IC50 values of compounds 5 and 8 were 26.14 ± 1.62 and 17.29 ± 6.28 µM, which were lower than that of the positive control, minocycline (IC50 = 30.26 ± 1.99 µM).
Collapse
Affiliation(s)
- Jinghui Wu
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou, China
| | - Wenxin Zhang
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou, China
| | - Jingwen Xu
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou, China
| | - Yihai Wang
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou, China
| | - Xiangjiu He
- School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, China
- Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangzhou, China
| |
Collapse
|
2
|
Porto-Barbosa T, Ramos LF, Pansa CC, Molica LR, Malaspina O, Moraes KCM. Inhibition of the miR-1914-5p increases the oxidative metabolism in cellular model of steatosis by modulating the Sirt1-PGC-1α pathway and systemic cellular activity. PLoS One 2024; 19:e0313185. [PMID: 39514580 PMCID: PMC11548759 DOI: 10.1371/journal.pone.0313185] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Accepted: 10/20/2024] [Indexed: 11/16/2024] Open
Abstract
Metabolic associated fatty liver disease (MAFLD) is considered an indicator of metabolic syndrome, which affects millions of people around the world and no effective treatment is currently available. MAFLD involves a wide spectrum of liver damage, that initiates from steatosis (fatty live) and may progress to more complex pathophysiology. Then, details in lipid metabolism controlling should be explored aiming to control the fatty liver. In this context, the miR-1914-5p can be considered a potential biotechnology tool to control lipid metabolism in hepatic cells. This miRNA finds potential mRNA binding sequences in more than 100 molecules correlated with energy production and lipid metabolism pointed in bioinformatic platforms. The present study addressed the miR-1914-5p effects in hepatic HepG2/LX-2 co-cultured cells in a in vitro steatotic environment stablished by the addition of 400 μM of a mixture of oleic and palmitic acids. The analyses demonstrated that the inhibition of the miRNA reduced energetic metabolites such as total lipids, triglycerides, cholesterol and even glucose. In addition, the miR-inhibitor-transfected cells did not present any deleterious effect in cellular environment by controlling reactive oxygen species production (ROS), mitochondrial membrane potential (ΔΨm) and even the pro-inflammatory environment. Moreover, the functional effect of the investigated miR, suggested its close connection to the modulation of Sirt-1-PGC1-α pathway, a master switch metabolic route that controlls cellular energetic metabolism. Our assays also suggested a synergistic effect of this miR-1914-5p in cell metabolism, which should be considered as a strong candidate to control steatotic environment in future clinical trials.
Collapse
Affiliation(s)
- Thais Porto-Barbosa
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Química, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Biotecnology, Campus Araraquara, Araraquara, SP, Brazil
| | - Letícia Ferreira Ramos
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Cellular, Molecular and Microbiology, Campus Rio Claro, Rio Claro SP, Brazil
| | - Camila Cristiane Pansa
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Cellular, Molecular and Microbiology, Campus Rio Claro, Rio Claro SP, Brazil
| | - Letícia Ramos Molica
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Química, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Biotecnology, Campus Araraquara, Araraquara, SP, Brazil
| | - Osmar Malaspina
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Cellular, Molecular and Microbiology, Campus Rio Claro, Rio Claro SP, Brazil
| | - Karen C. M. Moraes
- Departamento de Biologia Geral e Aplicada, Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”—Campus Rio Claro, Rio Claro, SP, Brazil
- Instituto de Química, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Biotecnology, Campus Araraquara, Araraquara, SP, Brazil
- Instituto de Biociências, Universidade Estadual Paulista “Júlio de Mesquita Filho”–Graduate Program in Cellular, Molecular and Microbiology, Campus Rio Claro, Rio Claro SP, Brazil
| |
Collapse
|
3
|
Spanoudaki M, Chrysafi M, Papadopoulou SK, Tsourouflis G, Pritsa A, Giaginis C. Naturally Occurring Compounds Targeting Peroxisome Proliferator Receptors: Potential Molecular Mechanisms and Future Perspectives for Promoting Human Health. APPLIED SCIENCES 2024; 14:9994. [DOI: 10.3390/app14219994] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2025]
Abstract
Background: Peroxisome-proliferator-activated receptors (PPARs) constitute nuclear transcription factors controlling gene expression associated with cell growth and proliferation, diverse proteins, lipids, and glucose metabolism, being related to several other pathophysiological states such as metabolic disorders, atherogenesis, carcinogenesis, etc. The present survey aims to analyze the natural compounds that can act as agonists for the PPAR-α, PPAR-β/δ, and PPAR-γ system targeting, highlighting how the amazing biochemical diversity of natural compounds can yield new insights into this “hotspot” of the scientific field. Methods: A narrative review was performed by searching the recent international literature for the last two decades in the most authoritative scientific databases, like PubMed, Scopus, Web of Science, and Embase, using appropriate keywords. Results: Several natural compounds and/or their synthetic derivatives can act as ligands of PPARs, stimulating their transcriptional activity and enabling their use as preventive and/or therapeutic agents for several disease states, such as inflammation, oxidative stress, metabolic disturbances, atherogenesis, and carcinogenesis. Although synthetic compounds are increasingly used as drugs to manage health problems, serious side effects have been observed, while their natural analogues exhibit only few minor side effects. Conclusions: Further clinical studies on natural compounds such as ligands of PPARs and the evaluation of the related molecular mechanisms are needed to implement an effective strategy concerning the pharmaco-technology, food chemistry, and nutrition to introduce them as part of clinical and dietary practice.
Collapse
Affiliation(s)
- Maria Spanoudaki
- Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece
- 424 General Military Hospital of Thessaloniki, 54621 Thessaloniki, Greece
| | - Maria Chrysafi
- Department of Food Science and Nutrition, School of Environment, University of Aegean, 81400 Lemnos, Greece
| | - Sousana K. Papadopoulou
- Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece
| | - Gerasimos Tsourouflis
- Second Department of Propedeutic Surgery, Medical School, University of Athens, 11527 Athens, Greece
| | - Agathi Pritsa
- Department of Nutritional Sciences and Dietetics, School of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece
| | - Constantinos Giaginis
- Department of Food Science and Nutrition, School of Environment, University of Aegean, 81400 Lemnos, Greece
| |
Collapse
|
4
|
Nishidono Y, Tanaka K. Phytochemicals of Alpinia zerumbet: A Review. Molecules 2024; 29:2845. [PMID: 38930910 PMCID: PMC11206972 DOI: 10.3390/molecules29122845] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2024] [Revised: 06/11/2024] [Accepted: 06/12/2024] [Indexed: 06/28/2024] Open
Abstract
Alpinia zerumbet (Pers.) B.L.Burtt & R.M.Sm is a perennial plant of the Zingiberaceae family widely distributed in the subtropical and tropical areas of South America, Oceania, and Asia. Multiple plant parts of A. zerumbet have been traditionally used as medicinal sources, each with different clinical uses. These variations may arise from differences among the chemical components and/or accumulations of the active compounds in each part. Therefore, this review summarizes previous studies on the phytochemicals in A. zerumbet and reveals the similarities and differences among the chemical constituents of its multiple medicinal parts, including the leaves, rhizomes, fruits, seeds, and flowers. The results contribute to the scientific validation of the traditional understanding that A. zerumbet possesses different medicinal properties in each plant part. In addition, this review provides directions for further studies on the phytochemicals of this plant.
Collapse
Affiliation(s)
- Yuto Nishidono
- College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu 525-8577, Shiga, Japan;
- Research Organization of Science and Technology, Ritsumeikan University, Kusatsu 525-8577, Shiga, Japan
| | - Ken Tanaka
- College of Pharmaceutical Sciences, Ritsumeikan University, Kusatsu 525-8577, Shiga, Japan;
| |
Collapse
|
5
|
Zuzarte M, Sousa C, Alves-Silva J, Salgueiro L. Plant Monoterpenes and Essential Oils as Potential Anti-Ageing Agents: Insights from Preclinical Data. Biomedicines 2024; 12:365. [PMID: 38397967 PMCID: PMC10886757 DOI: 10.3390/biomedicines12020365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2023] [Revised: 01/25/2024] [Accepted: 01/26/2024] [Indexed: 02/25/2024] Open
Abstract
Ageing is a natural process characterized by a time-dependent decline of physiological integrity that compromises functionality and inevitably leads to death. This decline is also quite relevant in major human pathologies, being a primary risk factor in neurodegenerative diseases, metabolic disorders, cardiovascular diseases and musculoskeletal disorders. Bearing this in mind, it is not surprising that research aiming at improving human health during this process has burst in the last decades. Importantly, major hallmarks of the ageing process and phenotype have been identified, this knowledge being quite relevant for future studies towards the identification of putative pharmaceutical targets, enabling the development of preventive/therapeutic strategies to improve health and longevity. In this context, aromatic plants have emerged as a source of potential bioactive volatile molecules, mainly monoterpenes, with many studies referring to their anti-ageing potential. Nevertheless, an integrated review on the current knowledge is lacking, with several research approaches studying isolated ageing hallmarks or referring to an overall anti-ageing effect, without depicting possible mechanisms of action. Herein, we aim to provide an updated systematization of the bioactive potential of volatile monoterpenes on recently proposed ageing hallmarks, and highlight the main mechanisms of action already identified, as well as possible chemical entity-activity relations. By gathering and categorizing the available scattered information, we also aim to identify important research gaps that could help pave the way for future research in the field.
Collapse
Affiliation(s)
- Mónica Zuzarte
- Univ Coimbra, Faculty of Pharmacy, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal; (J.A.-S.); (L.S.)
- Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal
- Clinical Academic Centre of Coimbra (CACC), 3000-548 Coimbra, Portugal
| | - Cátia Sousa
- iNOVA4HEALTH, NOVA Medical School, Faculdade de Ciências Médicas (NMS/FCM), Universidade Nova de Lisboa, 1159-056 Lisboa, Portugal;
- Centro Clínico e Académico de Lisboa, 1156-056 Lisboa, Portugal
| | - Jorge Alves-Silva
- Univ Coimbra, Faculty of Pharmacy, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal; (J.A.-S.); (L.S.)
- Univ Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal
- Clinical Academic Centre of Coimbra (CACC), 3000-548 Coimbra, Portugal
| | - Lígia Salgueiro
- Univ Coimbra, Faculty of Pharmacy, Azinhaga de S. Comba, 3000-548 Coimbra, Portugal; (J.A.-S.); (L.S.)
- Univ Coimbra, Chemical Engineering and Renewable Resources for Sustainability (CERES), Department of Chemical Engineering, 3030-790 Coimbra, Portugal
| |
Collapse
|